Biosimilars reshape immunology care across EU a decade after market entry [Advocacy Lab]

Ten years after the first etanercept biosimilar entered the European market, biosimilars have helped expand access to biologic therapies for millions of patients

This story was reported by Euractiv. EUROPES curates Europe's most relevant coverage — read the full report at the original source.